CH602117A5 - - Google Patents
Info
- Publication number
- CH602117A5 CH602117A5 CH890773A CH890773A CH602117A5 CH 602117 A5 CH602117 A5 CH 602117A5 CH 890773 A CH890773 A CH 890773A CH 890773 A CH890773 A CH 890773A CH 602117 A5 CH602117 A5 CH 602117A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7222208A FR2189021A1 (en) | 1972-06-20 | 1972-06-20 | Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues |
| FR7316130A FR2227862A1 (en) | 1973-05-04 | 1973-05-04 | Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH602117A5 true CH602117A5 (US08118993-20120221-C00002.png) | 1978-07-31 |
Family
ID=26217170
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH890773A CH602117A5 (US08118993-20120221-C00002.png) | 1972-06-20 | 1973-06-19 | |
| CH1284476A CH592452A5 (US08118993-20120221-C00002.png) | 1972-06-20 | 1973-06-19 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1284476A CH592452A5 (US08118993-20120221-C00002.png) | 1972-06-20 | 1973-06-19 |
Country Status (10)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2320107A1 (fr) * | 1975-08-05 | 1977-03-04 | Anvar | Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant |
| FR2321896A1 (fr) * | 1975-08-29 | 1977-03-25 | Anvar | Agents adjuvants immunologiques actifs en solution aqueuse |
| JPS54140710A (en) * | 1978-03-10 | 1979-11-01 | Mitsui Toatsu Chem Inc | Anti-tumor substance and its preparation |
| JPS5846363Y2 (ja) * | 1978-10-30 | 1983-10-21 | 三洋電機株式会社 | 太陽熱集熱器 |
| FR2444464A1 (fr) * | 1978-12-19 | 1980-07-18 | Fabre Sa Pierre | Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant |
| JPS568320A (en) * | 1979-07-04 | 1981-01-28 | Chisato Maruyama | Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent |
| FI75578C (fi) * | 1979-07-25 | 1988-07-11 | Ciba Geigy Ag | Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider. |
| JPS5632490A (en) * | 1979-08-28 | 1981-04-01 | Mitsui Toatsu Chem Inc | Antitumor active substance and its pharmaceutical |
| JPS5632489A (en) * | 1979-08-28 | 1981-04-01 | Mitsui Toatsu Chem Inc | Antitumor active substance and its pharmaceutical |
| EP0026746B1 (de) * | 1979-10-02 | 1985-04-10 | Ciba-Geigy Ag | Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung |
| FR2490495A1 (fr) * | 1980-09-19 | 1982-03-26 | Roussel Uclaf | Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant |
| FR2490496A1 (fr) * | 1980-09-19 | 1982-03-26 | Roussel Uclaf | Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant |
| EP0056560A1 (de) * | 1981-01-19 | 1982-07-28 | Ciba-Geigy Ag | Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika |
| US4503048A (en) * | 1982-06-30 | 1985-03-05 | Ribi Immunochem Research, Inc. | Pyridine soluble extract of a microorganism |
| US4505903A (en) * | 1982-06-30 | 1985-03-19 | Ribi Immunochem Research, Inc. | Pyridine soluble extract of a microorganism |
| US4504473A (en) * | 1982-06-30 | 1985-03-12 | Ribi Immunochem Research, Inc. | Pyridine soluble extract of a microorganism |
| CA1209504A (en) * | 1982-06-30 | 1986-08-12 | John L. Cantrell | Pyridine soluble extract of a microorganism |
| US4613504A (en) * | 1983-09-23 | 1986-09-23 | Ribi Immunochem Research, Inc. | Pyridine-soluble extracts of microorganisms |
| US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
| ATE154759T1 (de) * | 1990-11-08 | 1997-07-15 | Univ London | Mycobacterium als adjuvans für antigene |
| ATE179333T1 (de) * | 1993-01-29 | 1999-05-15 | Vetrepharm Inc | Immunotherapeutische zubereitung |
| US5985287A (en) * | 1996-08-29 | 1999-11-16 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6406704B1 (en) | 1996-08-29 | 2002-06-18 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6160093A (en) * | 1996-08-29 | 2000-12-12 | Genesis Researth And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| JP2001519785A (ja) * | 1997-04-02 | 2001-10-23 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | 局所的障害および創傷の治療のための細菌細胞壁抽出物の使用 |
| US5968524A (en) * | 1997-12-23 | 1999-10-19 | Genesis Research & Development Corp. | Methods and compounds for the treatment of immunologically-mediated psoriasis |
| US6328978B1 (en) | 1997-12-23 | 2001-12-11 | Genesis Research & Development Corp. Ltd. | Methods for the treatment of immunologically-mediated skin disorders |
| US20040247622A1 (en) * | 1999-06-02 | 2004-12-09 | Genesis Research And Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae |
| US6350457B1 (en) | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| KR101096577B1 (ko) * | 2010-03-09 | 2011-12-21 | 백태현 | 항산균 세포벽골격의 제조 방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3529057A (en) * | 1964-08-14 | 1970-09-15 | Takeda Chemical Industries Ltd | Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections |
-
1973
- 1973-06-18 NL NL7308450A patent/NL7308450A/xx not_active Application Discontinuation
- 1973-06-19 HU HU73AA740A patent/HU172600B/hu unknown
- 1973-06-19 CH CH890773A patent/CH602117A5/xx not_active IP Right Cessation
- 1973-06-19 US US05/371,658 patent/US3956481A/en not_active Expired - Lifetime
- 1973-06-19 CA CA174,439A patent/CA1006836A/en not_active Expired
- 1973-06-19 GB GB2899273A patent/GB1439847A/en not_active Expired
- 1973-06-19 IL IL42545A patent/IL42545A/en unknown
- 1973-06-19 DE DE2331144A patent/DE2331144A1/de active Pending
- 1973-06-19 JP JP48069140A patent/JPS4954590A/ja active Pending
- 1973-06-19 CH CH1284476A patent/CH592452A5/xx not_active IP Right Cessation
-
1976
- 1976-04-12 SE SE7604289A patent/SE7604289L/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE7604289L (sv) | 1976-04-12 |
| CH592452A5 (US08118993-20120221-C00002.png) | 1977-10-31 |
| US3956481A (en) | 1976-05-11 |
| IL42545A0 (en) | 1973-08-29 |
| CA1006836A (en) | 1977-03-15 |
| DE2331144A1 (de) | 1974-01-10 |
| JPS4954590A (US08118993-20120221-C00002.png) | 1974-05-27 |
| NL7308450A (US08118993-20120221-C00002.png) | 1973-12-27 |
| IL42545A (en) | 1977-05-31 |
| GB1439847A (en) | 1976-06-16 |
| HU172600B (en) | 1977-11-28 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |